Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-11

Clinical Trial Update: nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD

View source ↗

Summary

This completed clinical trial (NCT03146611) evaluated whether nCD64 or the neutrophil/lymphocyte ratio better predicts in-hospital outcomes during acute COPD ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: COPD Exacerbation, Copd | Status: COMPLETED